Bernard Stulberg, MD
Orthopaedic Surgery · Solon, OHNPI 1538120738
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $514,463 of the $766,935 with a category attached, or 67.1%. Exactech, Inc. accounts for 73.2% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2019 at $238,052 and has fallen 90.4% since, to $22,883 in 2025. Among orthopaedic surgery clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 130 payments — averaging $5899.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Exactech, Inc.$561K
- Think Surgical, Inc.$203K
- AbbVie$975
- Stryker$755
- Zimmer Biomet$125
- Johnson & Johnson$113
- plus $293 from 4 others
Across 21 payments — averaging $7641.27 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Think Surgical, Inc.$127K
- Exactech, Inc.$33K
- Omnilife Science, Inc$250
What the payments were for
- Royalty or licence$514,46367%
- Consulting fees$213,49528%
- Speaking & faculty fees$17,4402%
- Travel & lodging$17,9542%
- Food & beverage$2,6080%
- Gifts$9750%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Exactech, Inc. | 44 | $561,488 |
| Think Surgical, Inc. | 68 | $203,187 |
| AbbVie | 1 | $975 |
| Stryker | 10 | $755 |
| Zimmer Biomet | 1 | $125 |
| Johnson & Johnson(2 entities) | 2 | $113 |
| Conformis, Inc. | 1 | $112 |
| Medacta USA, Inc. | 1 | $100 |
| Avanos Medical | 1 | $62 |
| Nextstep Arthropedix, LLC | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OPTETRAK$283,281
- TRULIANT$255,877
- Tsolution One Surgical System$202,131
- NOVATION HIP$22,044
- EQUINOXE$17,440
- NATRELLE$975
- MAKO$450
- Persona Revision$125
- iTotal Identity PS$112
- Identity Imprint Knee Replacement System$112
- TRIATHLON$105
- ECHELON FLEX Stapler$104
- ENSEAL Product Family$104
- STRATAFIX$104
- AMISTEM$100
How this compares
$766,935 in reported general payments places this provider in the 95th percentile of 794 orthopaedic surgery providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Etodolac | 18 | $476 |
| Oxycodone Hcl | 28 | $174 |
| Meloxicam | 50 | $98 |
| Amoxicillin | 12 | $44 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Solon
- Reuben GobezieCleveland$12M
- Gregory BerletWorthington$9.6M
- Wael BarsoumCleveland$8.9M
- Brian CohenChillicothe$8.8M
- Joseph IannottiCleveland$7.1M
- John SontichYoungstown$3.6M
- Anthony MiniaciCleveland$3.1M
- David WelkerMiamisburg$2.8M
- Kenneth GreeneCleveland$2.6M
- Mark FroimsonCleveland$2.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.